Should Ondas’ Australian Counter‑Drone Win and DZYNE Deal Require Action From Ondas (ONDS) Investors?
Ondas Holdings ONDS | 0.00 |
- Earlier this month, Ondas Holdings approved the acquisition of DZYNE Technologies and secured a US$6.9 million order from the Australian Department of Defence for its Detect, Track, Identify, and Mitigate single-operator counter‑sUAS kits, delivered in partnership with HIFraser.
- This combination of defense-focused M&A and an international counter‑drone contract highlights Ondas’ growing role as a supplier of integrated unmanned and air-defense technologies to allied militaries.
- We’ll now examine how this Australian counter‑sUAS contract could reshape Ondas’ defense backlog narrative and its long-term growth profile.
The latest GPUs need a type of rare earth metal called Dysprosium and there are only 29 companies in the world exploring or producing it. Find the list for free.
Ondas Investment Narrative Recap
To own Ondas, you need to believe its push into autonomous defense and counter‑drone systems can translate a growing backlog into sustainable, higher margin revenue while the company manages dilution and execution risk. The Australian US$6.9 million counter‑sUAS order reinforces the near term defense story, but does not by itself resolve concerns around share issuance, capital raises and the volatility created by one off items in recent results.
In this context, the move to acquire DZYNE Technologies feels especially relevant. Folding DZYNE into Ondas’ existing counter‑UAS and unmanned portfolio could influence how effectively the company turns its growing defense footprint into orders similar to the Australian contract, which matters for both the current defense backlog narrative and how investors weigh the risk that heavy M&A and integration spending might outpace realized revenue.
Yet against this progress, investors should still be aware of the risk that repeated equity raises and share authorizations could...
Ondas’ narrative projects $1.0 billion revenue and $114.4 million earnings by 2029.
Uncover how Ondas' forecasts yield a $20.12 fair value, a 193% upside to its current price.
Exploring Other Perspectives
The most cautious analysts were assuming revenue could reach about US$888 million by 2029 while still questioning earnings quality and M&A integration, so this Australian defense win may ultimately shift how you weigh that much more pessimistic path against the possibility that Ondas converts its acquisition pipeline and large cash balance into a stronger autonomous defense backlog story.
Explore 13 other fair value estimates on Ondas - why the stock might be worth 24% less than the current price!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Ondas research is our analysis highlighting 5 key rewards and 4 important warning signs that could impact your investment decision.
- Our free Ondas research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ondas' overall financial health at a glance.
Curious About Other Options?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Capitalize on the AI infrastructure supercycle with our selection of the 54 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
